Baxter International Inc. vs. Haemonetics Corporation
Baxter International Inc. (BAX) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BAX | HAE | |
|---|---|---|
| Market Cap | $12.85 billion | $4.68 billion |
| Revenue (TTM) | $11.47 billion | $1.35 billion |
| Net Income (TTM) | $-1,063,000,000 | $96.29 million |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | HAE | |
|---|---|---|
| P/E Ratio | — | 49.68 |
| Price / Book | 2.08 | 5.59 |
| Price / Sales | 1.12 | 3.46 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | HAE | |
|---|---|---|
| Net Margin | -9.27% | 7.12% |
| Return on Equity | -17.20% | 11.50% |
HAE leads on 2 of 2 profitability factors.
Dividend
| BAX | HAE | |
|---|---|---|
| Dividend Yield | 0.16% | — |
BAX and HAE split the dividend factors evenly.
Risk & Sentiment
| BAX | HAE | |
|---|---|---|
| Short Interest | 1.03% | 1.81% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, HAE overview, HAE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.